03 June 2026
: Case report
[In Press] Histoplasmosis-Associated Hemophagocytic Lymphohistiocytosis Presenting as Pyrexia of Unknown Origin With Splenic Masses
Unusual clinical course, Challenging differential diagnosis, Unusual setting of medical care, Unexpected drug reaction, Rare disease, Educational Purpose (only if useful for a systematic review or synthesis)
Nidhi Gupta1ABCDEF, Kriti Yadav1CDF, Mythri Chittilla1DF, Charly Almonte1EF, Rahul Sampath1ABCDGDOI: 10.12659/AJCR.952791
Am J Case Rep In Press; DOI: 10.12659/AJCR.952791
Available online: 2026-06-03, In Press, Corrected Proof
Publication in the "In-Press" formula aims at speeding up the public availability of the pending manuscript while waiting for the final publication. The assigned DOI number is active and citable. The availability of the article in the Medline, PubMed and PMC databases as well as Web of Science will be obtained after the final publication according to the journal schedule
Abstract
BACKGROUND
Histoplasma capsulatum is a thermally dimorphic fungus capable of causing progressive disseminated histoplasmosis, particularly in immunocompromised hosts. Hemophagocytic lymphohistiocytosis (HLH) is a rare, life-threatening hyperinflammatory syndrome resulting from uncontrolled immune activation. The coexistence of HLH and disseminated histoplasmosis is uncommon and poses significant diagnostic and therapeutic challenges.
CASE REPORT
A 72-year-old immunosuppressed woman with rheumatoid arthritis treated with methotrexate, hydroxychloroquine, and adalimumab presented with a 2-month history of intermittent high-grade fevers, weight loss, fatigue, and left upper quadrant pain. Physical examination revealed pallor, lethargy, and splenomegaly. Laboratory evaluation showed pancytopenia, markedly elevated ferritin, hypertriglyceridemia, and hypofibrinogenemia. Imaging demonstrated splenomegaly with splenic masses, hepatic lesions, and pulmonary nodules. Disseminated histoplasmosis was confirmed by positive urine Histoplasma antigen testing, immunodiffusion assays (H and M bands), and tissue biopsy demonstrating intracellular yeast forms consistent with Histoplasma. Bone marrow biopsy revealed hypercellularity with histiocytosis and hemophagocytosis. Elevated soluble interleukin-2 receptor levels and decreased natural killer cell activity supported secondary HLH. The patient was treated with liposomal amphotericin B followed by oral itraconazole, resulting in rapid clinical improvement and normalization of inflammatory markers, with radiographic resolution at 12 months. This case is notable for HLH associated with disseminated histoplasmosis presenting with splenic masses, an uncommon finding that can mimic malignancy or other infectious etiologies.
CONCLUSIONS
This case underscores the importance of considering HLH in patients with disseminated histoplasmosis presenting with persistent fever, cytopenias, and organomegaly. Early recognition and prompt antifungal therapy are critical for favorable outcomes. Although histoplasmosis can occur in immunocompetent individuals, it more commonly affects immunocompromised hosts, as in this patient, highlighting the need for vigilance in high-risk populations.
Keywords: Histoplasmosis
In Press
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.949976
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.950290
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.950607
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.950985
Most Viewed Current Articles
07 Dec 2021 : Case report
17,691,734
DOI :10.12659/AJCR.934347
Am J Case Rep 2021; 22:e934347
06 Dec 2021 : Case report
164,491
DOI :10.12659/AJCR.934406
Am J Case Rep 2021; 22:e934406
21 Jun 2024 : Case report
113,090
DOI :10.12659/AJCR.944371
Am J Case Rep 2024; 25:e944371
07 Mar 2024 : Case report
59,175
DOI :10.12659/AJCR.943133
Am J Case Rep 2024; 25:e943133






